!-- Google Tag Manager -->
The Promise and Potential of CAR T-Cell Therapy in Rheumatology: Emerging Evidence and Key Insights for Real-World Integration and Patient Care
Feb 08

The Promise and Potential of CAR T-Cell Therapy in...

 

map
Click on the Map to see the location
  • return-icon-whiteReturn to Summit Events




    The Promise and Potential of CAR T-Cell Therapy in Rheumatology: 
    Emerging Evidence and Key Insights for Real-World Integration and Patient Care

    Registration link: Click here hands icon purp

    icon pur peopl

    Join our upcoming webinar to explore the transformative potential of CAR T-cell therapy in rheumatology!   

    Originally developed for hematologic cancers, this cutting-edge treatment is now being investigated for autoimmune diseases like systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and idiopathic inflammatory myopathies (IIM) – showing promise in achieving durable, drug-free remission in patients with severe disease who have not responded to existing therapies. 

    With new clinical trials and emerging data, this session will provide expert insights into the evolving evidence, practical considerations for patient selection, and interprofessional strategies to address the challenges of cost, complexity, and equitable access. 

    Don’t miss this opportunity to hear directly from leading experts who have pioneered the study and application of CAR T-cell therapy in real-world settings so you can stay ahead of the curve in integrating this groundbreaking technology into rheumatology care. 

    Plus, you can earn 1.5 CME/MOC! Register now for FREE.  


    How To Participate 

    This is a virtual event, so please register following these 3 easy steps:

    1. Go to our registration page and register for the Summit.
    2. Save your registration email with your link and login information.
    3. Log in to the virtual meeting app during the Summit to participate!

    The companion virtual meeting app allows you to watch the Summit livestream, review the program agenda and faculty information, send questions, participate in polling questions, complete pre- and post-activity surveys, and find information to claim CME/MOC credits!


    Please note: you must register and complete the poll/survey questions in the virtual meeting app to claim your free CME credits.


    Watch Party Locations – Coming Soon!
     

    Summit Details

    1

    Date: February 8th, 2025

    Time: 12:00 PM – 15:20 EST

    1


    Location: Virtual with Community Locations

    * Join a Local Watch Party to network with your colleagues and enjoy a memorable meal while watching the presentations. Locations will be added over time; you can register now as a virtual attendee and modify your registration to pick a Watch Party later.

    icon pur peopl

    Chairs:

    • Grace C. Wright, MD, PhD, FACR
      AWIR President and Founder
    • Priya Reddy, MD, FACR
      AWIR Secretary and Treasurer
    User Image - Dr.Wright User Image -Priya Reddy
    icon pur peopl

    Speakers

    • David L. Porter, MD
      Jodi Fisher Horowitz Professor of Leukemia Care Excellence
      Director, Center for Cell Therapy and Transplant
      University of Pennsylvania
    • Peter A. Merkel, MD, MPH 
      Chief, Division of Rheumatology
      Professor of Medicine and Epidemiology
      University of Pennsylvania


    Program


    12:00-12:10 - Welcome Remarks

    12:10-12:40  - Educational Symposium

    12:40-14:10 -  Accredited Session (1.5 CME/MOC) 

    14:10-14:25 
    - Break

    14:25-14:40 
    - Roundtable

    14:40-15:10 
    - Product Theater: Sponsored by UCB

    15:10-15:20 
    - Closing Remarks

     

    CME Session Information


    Learning Objectives:

    • Describe the principles, mechanisms, and administration of new and emerging CAR T-cell therapies.
    • Evaluate the latest clinical safety and efficacy data on emerging CAR T-cell therapies for the treatment of rheumatic conditions. 
    • Apply patient factors and disease characteristics to identify patients with rheumatic diseases who would benefit from CAR T-cell therapy.
    • Incorporate interprofessional strategies for optimal access to, administration of, and monitoring of CAR T-cell therapies in patients with rheumatic diseases.  


      icon pur peopl

    Agenda: 

    • Overview of CAR T-Cell Therapy: Principles, Mechanisms, and Administration
    • Current Use of CAR T-Cell Therapy: Evidence and Experience in Hematology & Oncology
    • Application of CAR T-Cell Therapy in Rheumatology: Clinical Trials and Early Data
    • Integration of CAR T-Cell Therapy in Rheumatology: Patient Diversity and Eligibility, System and Team Resources, and Equitable Care

       

    Registration link: Click here hands icon purp

  • Category
    Summits
  • Date & Time
    Feb 08 2025 at 12:00 - Feb 08 2025 at 15:30
  • Location & full address
    Virtual with Community Watch Parties*
;